Latest Commercialization News

Silver Mines has completed the $26 million buyback and extinguishment of two private royalties over its Bowdens Silver Project, paying $18 million in cash and issuing $8 million in shares. The move removes the royalty interests over EL5920 as the project enters its next approvals phase.

Temas Resources and SAGA Metals have begun an eight-week optimisation program aimed at turning strong laboratory recoveries into a defined processing flowsheet and first high-purity titanium, vanadium and iron products. A successful stage could lead to a C$650,000-C$750,000 mini-pilot, although that funding remains subject to technical results and SAGA approval.

Li-S Energy has narrowed its FY26 loss and reached several commercialisation milestones, including a 2C Power Cell, international shipping approvals and its first lithium foil sale. But the ASX battery developer still needs customer offtake and fresh funding before its proposed 1 GWh manufacturing expansion can become reality.

Memphasys will receive an A$3.5 million advance from major shareholder Peters Investments to expand Felix production, inventory and sales capacity as repeat orders emerge across international markets. The funding carries a 12.5% interest rate, potential equity dilution and requires shareholder and ASX approvals before the convertible notes can be issued.

Stakk has secured a live signature verification engagement for use by the United States Federal Bureau of Investigation through ParaScript, with the agreement running to December 2027. The company says the contract will contribute meaningfully to its FY2027 revenue target, now expected to exceed $55 million, although its value remains confidential.

Prairie Limited has secured C$6.3 million in interest-free Canadian government financing to fund the next construction phase of its Saskatchewan lithium project. The company is targeting commissioning and first lithium brine production from its initial commercial well in Q4 2026.

Strike Energy is moving from construction into execution, with its 85 MW South Erregulla power project nearing commercial operations and a 251 PJ West Erregulla reserve base underpinning its next gas development. The opportunity comes with a weaker FY26 earnings result, A$111.4 million of net debt and major funding obligations arriving from late 2026.

Sea Forest has reported a sharp lift in SeaFeed revenue during its first full year as an ASX-listed company, but remains loss-making as it funds production and market expansion. The methane-reduction specialist ended FY26 with $27.8 million in cash and term deposits and no borrowings.

Lake Resources has secured the primary provincial environmental permit for its Kachi lithium project in Argentina, clearing the way for detailed engineering and financing work. The approval removes a major development hurdle, but FEED, funding, RIGI approval and a final investment decision remain ahead.

IperionX has moved its Virginia titanium operation into 24/7 production, lifting nameplate powder capacity to about 200 tonnes a year while commissioning equipment aimed at higher-value components. The progress came alongside a US$66.8 million annual loss, US$63.5 million of operating and investing cash outflows, and continued reliance on government support, customer qualification and future capital.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

WhiteRock Lithium has intersected spodumene-bearing pegmatite in all 10 newly reported drill holes at its Spodumene Mountain prospect in Québec. The visual results strengthen the geological case for continuity, but assays and true widths are still pending.